Tag Archives: Stem Cells Inc

StemCells, Inc. Announces Termination of Phase II Pathway Study Following Review of Data

Posted on May 31, 2016 by

NEWARK, Calif., May 31, 2016 (GLOBE NEWSWIRE) — StemCells, Inc. (STEM) (the “Company”) today announced its decision to terminate the Company’s Phase II Pathway Study in spinal cord injury following an in-depth review of data from the study and after … Continue reading →

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Stem Cell Research | Tagged

Stem Cells Inc announces new CEO and chronic SCI focus going forward

Posted on January 22, 2016 by

StemCells, Inc. (NASDAQ:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of central nervous system disorders, today announced that Dr. Ian Massey, its President and Chief Operating Officer, has been appointed by the Board … Continue reading →

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Stem Cell Research | Tagged ,

Positive Six-Month Results, With Gains in Both Strength and Motor Function, for the First Cohort in the Phase II Pathway Study

Posted on November 18, 2015 by

Positive Six-Month Results, With Gains in Both Strength and Motor Function, for the First Cohort in the Phase II Pathway Study NEWARK, Calif., Nov. 18, 2015 (GLOBE NEWSWIRE) — StemCells, Inc.(NASDAQ:STEM), a world leader in the research and development of … Continue reading →

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Stem Cell Research | Tagged | 2 Comments

Alliance for Regenerative Medicine: Stem Cells 2014

Posted on October 30, 2014 by

Presented by: Teresa Leezer, CEO RhinoCyte, Inc. is a privately owned biopharmaceutical company focused on developing transformational technologies that will change the way neurodegenerative disorders are treated. Founded in 2005, the Company is advancing innovative treatment paradigms that leverage proprietary … Continue reading →

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Stem Cell Research | Tagged , , , ,

Stem Cells Inc. update at Alliance for Regenerative Medicine (ARM)

Posted on April 7, 2014 by

Martin McGlynn, President and CEO of Stem Cells Inc. gives an update on Investor Day in New York City. For spinal cord injury they plan to release data in the second quarter of 2014 and open 20-30 additional sites to … Continue reading →

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Stem Cell Research | Tagged , ,

What the Community Wants to Know! Aileen Anderson PhD, Stephen Huhn MD and Dr Thomas Answer Questions about StemCells Inc.

Posted on January 22, 2013 by

These online video presentations from the W2W 2012 symposium are only made possible through your generous contributions to U2FP. Aileen Anderson PhD,  Stephen Huhn MD, Dr. Jonathan Thomas answer questions about the StemCells Inc. human clinical trial in Zurich.

Posted in Advocacy, Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, spinal cord injury research, Stem Cell Research | Tagged , , , , , , , , , , , , , , , , , , , , ,

Aileen Anderson, PhD. – Presents at Working 2 Walk 2012

Posted on December 17, 2012 by

These online video presentations from the W2W 2012 symposium are only made possible through your generous contributions to U2FP. Aileen Anderson, PhD. Associate Professor, Reeve-Irvine Research Center “Stem Cell Strategies for Spinal Cord Injury: Managing the Microenvironment” Dr. Anderson investigates … Continue reading →

Posted in Advocacy, Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Stem Cell Research | Tagged , , , , , , , , , , , , , , , , , ,

Stephen Huhn, MD. – Presents at Working 2 Walk 2012

Posted on December 12, 2012 by

These online video presentations from the W2W 2012 symposium are only made possible through your generous contributions to U2FP. Stephen Huhn, MD, FACS, FAAP, Vice President, Head of the CNS Program, Stem Cells, Inc. “Phase I/II Study of Human Neural … Continue reading →

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research, Stem Cell Research | Tagged , , , , , , , , , , ,

Dr. Armin Curt: Update on the Stem Cells Inc. Clinical Trial

Posted on December 2, 2012 by

Dr. Armin Curt, Professor and Chairman, Spinal Cord Injury Center at the University of Zurich, and Medical Director of the Paraplegic Center at the Balgrist University Hostpital, discusses latest clinical research in the use of neural stem cells to treat … Continue reading →

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research | Tagged , , ,

Working 2 Walk 2012 Science and Advocacy Symposium video presentations from Unite 2 Fight Paralysis will debut online!

Posted on November 16, 2012 by

Unite 2 Fight Paralysis hosted the annual Working 2 Walk Science and Advocacy Symposium in Irvine California for 2012. If you share our mission and goals, please consider making a donation that will help us continue this desperately needed work. … Continue reading →

Posted in Advocacy, Biomaterials, Chronic Spinal Cord Injury Research, Neuroscience Abstracts, Regenerative Medicine, Rehabilitation, spinal cord injury research, Stem Cell Research | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,